[Central action of natriuretic peptides].
Katsuura
Goro
G
Discovery Research Laboratories, Shionogi & Co. Ltd.
D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000502:physiology; D000818:Animals; D001253:Astrocytes / Q000378:metabolism; D001794:Blood Pressure; D001921:Brain / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D004326:Drinking / Q000187:drug effects; D006162:Guanylate Cyclase / Q000502:physiology; D006801:Humans; D045265:Natriuretic Peptides / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D017461:Receptors, Atrial Natriuretic Factor / Q000502:physiology; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled; D018000:Receptors, Peptide / Q000502:physiology; D013564:Sympathetic Nervous System / Q000187:drug effects; D014667:Vasopressins / Q000378:metabolism; D014882:Water-Electrolyte Balance / Q000187:drug effects; D000099242:Atrial Natriuretic Factor Receptor B
D000804:Angiotensin II; D006152:Cyclic GMP; D006162:Guanylate Cyclase; D045265:Natriuretic Peptides; D017461:Receptors, Atrial Natriuretic Factor; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled; D018000:Receptors, Peptide; D014667:Vasopressins; D000099242:Atrial Natriuretic Factor Receptor B; C091715:atrial natriuretic factor receptor A